ATAI LIFE SCIENCES NV (9VC.DE) Stock Income Statement
FRA:9VC - Deutsche Boerse Ag - NL0015000DX5 - Common Stock - Currency: EUR
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 331.00K | 314.00K | 230.00K | 20.38M | 0.00 | |||
| Minority Interest Expense | 1.60M | 3.67M | 5.03M | 6.44M | 8.78M | |||
| Operating Expenses | 104.31M | 122.58M | 144.67M | 140.70M | 92.15M | |||
| Research and Development | 50.37M | 60.40M | 74.31M | 47.96M | 11.41M | |||
| Selling, General, and Administrative Expenses | 53.94M | 62.18M | 70.35M | 92.75M | 80.73M | |||
| Operating Income | -103.98M | -122.27M | -144.43M | -120.33M | -92.15M | |||
| Interest Income/Expense | -70.26M | -1.70M | 7.45M | -3.42M | 20.08M | |||
| Other Income/Expense | 49.65M | 88.74M | 670.00K | 3.14M | -17.22M | |||
| Non Recurring Items | N/A | -4.05M | 1.13M | -15.99M | -12.52M | |||
| Income Before Taxes | -127.54M | -39.29M | -135.18M | -136.60M | -101.81M | |||
| Income Tax | 265.00K | 1.02M | 6.23M | -3.99M | 310.00K | |||
| Net Income | -128.60M | -40.22M | -152.39M | -167.81M | -169.84M | |||
| EBITDA | -103.63M | -121.95M | -144.26M | -120.28M | -92.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.80 | -0.25 | -0.98 | -1.21 | -1.11 | |||
| Non GAAP EPS | -0.81 | -0.29 | -0.98 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -38852.87% | -12810.19% | -66256.52% | -823.41% | N/A | |||
| Operating Profit Margin | -31412.99% | -38939.81% | -62795.65% | -590.43% | N/A | |||
All data in USD